Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of central nervous system (CNS) drugs. Its rigid azabicyclic structure and functional groups make it valuable for designing enzyme inhibitors and receptor modulators. The presence of trifluoromethyl group enhances metabolic stability and bioavailability, which is beneficial in optimizing drug candidates for improved pharmacokinetics. Commonly employed in medicinal chemistry for structure-activity relationship (SAR) studies, especially in projects targeting neurological disorders such as depression, anxiety, and epilepsy.